Quarterly report pursuant to Section 13 or 15(d)

Extab Acquisition (Tables)

v3.8.0.1
Extab Acquisition (Tables) - Extab [Member]
 9 Months Ended
Sep. 30, 2017
Business Acquisition [Line Items]  
Summary of Final Purchase Price

The purchase price of Achieve’s 75% controlling interest in Extab was as follows:

 

 

 

Fair Value

 

Cash consideration

 

$

2,000

 

Contingent consideration

 

 

—

 

Purchase Price

 

$

2,000

 

 
Summary of Final Purchase Price Allocation

The allocation of the purchase price based on the estimated fair values is as follows:

 

 

Fair Value

 

Cash

 

$

6

 

License agreements

 

$

3,117

 

Goodwill

 

$

1,034

 

Other current liabilities

 

$

(456

)

Deferred tax liability

 

$

(1,034

)

Non-controlling interest

 

$

(667

)

 

 

$

2,000